Primary hyperparathyroidism

MD Walker, SJ Silverberg - Nature Reviews Endocrinology, 2018 - nature.com
In this Review, we describe the pathogenesis, diagnosis and management of primary
hyperparathyroidism (PHPT), with a focus on recent advances in the field. PHPT is a …

Parathyroid hormone: anabolic and catabolic actions on the skeleton

BC Silva, JP Bilezikian - Current opinion in pharmacology, 2015 - Elsevier
Highlights•Parathyroid hormone has dual anabolic and catabolic actions on the
skeleton.•The OPG–RANKL–RANK pathway is the main mediator of the catabolic actions of …

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop

SJ Silverberg, BL Clarke, M Peacock… - The Journal of …, 2014 - academic.oup.com
Objective: This report summarizes data on traditional and nontraditional manifestations of
primary hyperparathyroidism (PHPT) that have been published since the last International …

The WNT system: background and its role in bone

UH Lerner, C Ohlsson - Journal of internal medicine, 2015 - Wiley Online Library
WNT s are extracellular proteins that activate different cell surface receptors linked to
canonical and noncanonical WNT signalling pathways. The Wnt genes were originally …

Involvement of WNT/β-catenin signaling in the treatment of osteoporosis

M Rossini, D Gatti, S Adami - Calcified tissue international, 2013 - Springer
Osteoblast differentiation is predominantly regulated by the WNT/β-catenin signaling
(canonical WNT pathway), which, together with bone morphogenetic proteins, acts as the …

Sclerostin: another vascular calcification inhibitor?

KJ Claes, L Viaene, S Heye, B Meijers… - The Journal of …, 2013 - academic.oup.com
Context: Sclerostin, a Wnt antagonist produced by osteocytes, regulates osteoblast activity
and is a well-established key player in bone turnover. Recent data indicate that the Wnt …

[HTML][HTML] Sclerostin and DKK1: new players in renal bone and vascular disease

P Evenepoel, P D'haese, V Brandenburg - Kidney international, 2015 - Elsevier
For more than a decade, the Wnt–β-catenin pathway has been the focus of intense basic
and clinical research in the bone field because of its importance in skeletal development …

Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness

S Thambiah, R Roplekar, P Manghat… - Calcified tissue …, 2012 - Springer
Abnormalities of bone metabolism and increased vascular calcification are common in
chronic kidney disease (CKD) and important causes of morbidity and mortality. The Wnt …

New emerging biomarkers for bone disease: sclerostin and Dickkopf-1 (DKK1)

AS Dincel, NR Jørgensen… - Calcified Tissue …, 2023 - Springer
A healthy skeleton depends on a continuous renewal and maintenance of the bone tissue.
The process of bone remodeling is highly controlled and consists of a fine-tuned balance …

High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study

MSM Ardawi, AA Rouzi, SA Al‐Sibiani… - Journal of Bone and …, 2012 - academic.oup.com
Sclerostin regulates bone formation by inhibiting Wnt pathway signaling. Low circulating
sclerostin levels cause high bone mass. We hypothesized that postmenopausal women with …